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Background: Quantification of the longitudinal- and transverse relaxation time in the myocardium has shown to
provide important information in cardiac diagnostics. Methods for cardiac relaxation time mapping generally
demand a long breath hold to measure either T1 or T2 in a single 2D slice. In this paper we present and evaluate a
novel method for 3D interleaved T1 and T2 mapping of the whole left ventricular myocardium within a single
breath hold of 15 heartbeats.
Methods: The 3D-QALAS (3D-quantification using an interleaved Look-Locker acquisition sequence with T2
preparation pulse) is based on a 3D spoiled Turbo Field Echo sequence using inversion recovery with interleaved
T2 preparation. Quantification of both T1 and T2 in a volume of 13 slices with a resolution of 2.0x2.0x6.0 mm is
obtained from five measurements by using simulations of the longitudinal magnetizations Mz. This acquisition
scheme is repeated three times to sample k-space. The method was evaluated both in-vitro (validated against
Inversion Recovery and Multi Echo) and in-vivo (validated against MOLLI and Dual Echo).
Results: In-vitro, a strong relation was found between 3D-QALAS and Inversion Recovery (R = 0.998; N = 10;
p < 0.01) and between 3D-QALAS and Multi Echo (R = 0.996; N = 10; p < 0.01). The 3D-QALAS method showed no
dependence on e.g. heart rate in the interval of 40–120 bpm. In healthy myocardium, the mean T1 value was 1083
± 43 ms (mean ± SD) for 3D-QALAS and 1089 ± 54 ms for MOLLI, while the mean T2 value was 50.4 ± 3.6 ms
3D-QALAS and 50.3 ± 3.5 ms for Dual Echo. No significant difference in in-vivo relaxation times was found between
3D-QALAS and MOLLI (N = 10; p = 0.65) respectively 3D-QALAS and Dual Echo (N = 10; p = 0.925) for the ten
healthy volunteers.
Conclusions: The 3D-QALAS method has demonstrated good accuracy and intra-scan variability both in-vitro and
in-vivo. It allows rapid acquisition and provides quantitative information of both T1 and T2 relaxation times in the
same scan with full coverage of the left ventricle, enabling clinical application in a broader spectrum of cardiac
disorders.
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In daily clinical practice cardiovascular magnetic reson-
ance (CMR) settings are generally chosen to highlight in-
tensity contrast between tissues. By varying parameters
such as the echo time, repetition time and flip angle it is
possible to create different contrast weighted images. The
absolute intensity in contrast weighted images is defined
on an arbitrary scale that differs from one examination to
another. Image interpretation thus relies on comparisons
with surrounding tissue. Recently it has become feasible
to obtain a quantitative measurement of the signal inten-
sity corresponding to the absolute value of the longitu-
dinal relaxation (T1), transverse relaxation (T2) and
proton density in many organs [1]. This enables numerical
comparison between different tissue compositions and
hence the objective detection of pathological processes by
measuring the deviation from the range of normal values.
Another important advantage of these quantitative images
is the application of synthetic CMR, which uses the abso-
lute parameters T1 and T2 to synthesize any T1-weighted
or T2-weighted contrast image [2]. In this way conven-
tional images can be interpreted with simultaneous access
to the quantitative parameters from the same acquisition.
For cardiac applications, both quantitative T1 maps and
quantitative T2 maps have been shown to provide import-
ant information. T1 maps have been successfully used to
identify the area of myocardial infarction and to assess
acute and chronic myocardial infarction [3]. Diffuse tissue
changes such as diffuse fibrosis may be quantified non-
invasively using T1 mapping where remote, normal,
myocardium is not accessible for comparison [4-6].
Quantitative T2-mapping techniques have been validated
in myocardial ischemia and edema [7,8] with robust re-
sults and increased accuracy in comparison with the com-
monly used T2-weighted images. In the assessment of
edema in ischemic and non-ischemic heart disease, even
native T1 mapping has provided helpful information [9].
Native T1- and T2-mapping techniques have also been
validated for the determination of the area at risk after
acute myocardial infarction [10]. Mapping of both relax-
ation parameters has potential for improving the differen-
tiation between myocardium affected by various diseases
and normal myocardium.
Various methods are available to quantify the absolute
parameters T1 and T2 in the heart. Due to cardiac mo-
tion and time constraints of the cardiac cycle, several
difficulties are associated with these methods. The major
drawback with the existing quantitative methods is the
long imaging time. An inversion recovery sequence can
be used to estimate values of T1 in the heart. To allow
full magnetization recovery between the radio frequency
inversion pulses a relaxation period of four to five times
T1 is necessary. Since T1 often has a value exceeding
the duration of the cardiac cycle, the clinical applicabilityof the method is limited. Look and Locker described a
multi point approach [11], where the relaxation curve is
sampled multiple times after the initial inversion pulse,
which contributes to accelerate the acquisition. The
drawback with the original Look Locker (LL) -method is
that it uses continuous data acquisition and not selective
data acquisition in a specific time frame of the cardiac
cycle. Messroghli et al. presented, a now established,
modified LL inversion recovery sequence (MOLLI) [12]
which uses selective data acquisition and multiple LL ex-
periments. The MOLLI sequence acquires in its original
format one single slice of the heart in 17 heartbeats,
which is a limitation to its clinical use since multiple
breath holds may be required to cover the myocardium.
A shortened version of MOLLI has also been presented
with good agreement to the original version [13], but
this is still a 2D mapping method providing a single slice
of the heart in one breath hold.
Three-dimensional T1-mapping methods of the heart
do exist but generally suffer from long imaging time. Re-
cently Coniglio et al. presented a 3D Inversion Recovery
T1 mapping method of the heart using both ECG and
respiratory triggers with accurate T1 estimates [14]. This
free-breathing method was reported to take 5–8 minutes
for six slices. Warntjes et al. presented a 3D single
breath hold method for T1, but this approach is only ap-
propriate at short T1 times, i.e. after administration of
Gd contrast agent [15].
A multi echo sequence can be used to estimate values
of T2 in the heart. Such a sequence often requires sev-
eral echo time points and thus several repetitions to get
a good signal to noise ratio in the T2 map and to sample
enough data, which then becomes time consuming. T2
mapping methods using T2-preparation pulses exists
and they appear to be robust and fast but they still only
provide a single 2D slice map [16].
In this paper we present and evaluate a novel method
for 3D interleaved T1 and T2 quantification of the whole




The sequence is based on a cardiac triggered 3D spoiled
fast gradient echo sequence, Turbo Field Echo, and
named 3D-QALAS (3D-QuAntification using an inter-
leaved Look-Locker Acquisition Sequence with T2 prepar-
ation pulse). The sequence block, described in Figure 1,
can be divided into two phases, one T2 sensitizing phase
and one T1 sensitizing phase, with five segmented acquisi-
tions that are run three times during a single breath hold.
The T2 sensitizing phase starts with a non slice-selective
90-degree RF pulse, followed by two 180-degree adiabatic
RF refocusing pulses in a time of 50 ms. During this time
Figure 1 Schematic overview of the proposed acquisition kernel. Five cardiac-triggered acquisitions (Acq1- Acq5) are performed during
end-diastole. Prior to the first acquisition a T2-sensitizing phase decreases the Mz magnetization proportional to the T2 relaxation. Prior to the
second acquisition a T1-sensitizing phase is applied to invert the Mz magnetization. No sensitizing phases are applied before the other acquisitions.
The typical Mz magnetization evolution is displayed as the grey dotted line. At each interval the magnetization is labeled as M1-M13.
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relaxation time. After the last 180-degree pulse, a 90-
degree RF pulse is applied to tilt the magnetization vector
back to the Mz axis.The result of the T2 sensitizing phase
is that T2 relaxation is encoded on the Mz axis. After the
T2 sensitizing phase a 3D turbo field echo data acquisition
is performed.
The T1 sensitizing phase consists of a non slice-selective
180-degree 3D adiabatic inversion pulse followed by gradi-
ent spoiling. After an inversion time of 100 ms, a second
acquisition is performed. During the following T1 relax-
ation, three more acquisitions are performed in consecu-
tive heartbeats.
The acquisition is hence performed once after the T2-
prep pulse and four times after the T1sensitizing inver-
sion pulse (5 heartbeats). The acquisitions use a flip
angle of 5°, a TFE-factor of 90, an echo time of 1.2 ms
and a repetition time of 2.6 ms. This acquisition scheme
is repeated three times to sample k-space, resulting in a
breath hold of 15 heartbeats.
The number of required k-space points is reduced due
to the use of elliptical k-space filling. The center of k-
space is sampled first and the periphery last (low-high
order). The acquisition is accelerated using a sensitivity
encoding (SENSE) reduction factor of 2 in the phase en-
coding (y) direction and a factor of 1.2 in the slice (z) dir-
ection. To minimize artifacts from cardiac motion the
acquisition window is restricted to 230 ms in end-diastole
by using cardiac ECG triggering. The resolution of the 3D
acquisition is 2.0 mm, 2.0 mm and 12 mm in the fre-
quency, phase and slice direction respectively. The data
was reconstructed to 2.0 mm × 2.0 mm × 6 mm, resulting
in thirteen short axis slices.
Calculation of parameters
T1 and T2 relaxation times are calculated from the five
measurements by simulations of the longitudinal magneti-
zations Mz. In the absence of RF pulses, during the delaytime between acquisitions, the Mz relaxes with a T1 relax-
ation time, approaching the unsaturated magnetization
M0. In Figure 1, T1 relaxation occurs during the intervals
M3-M4, M5–M6, M7–M8, M9–M10, M11–M12 and M13–
M1. During this period each magnetization Mn+1 can be
calculated from a previous magnetization Mn with a time
interval Δt according to:
Mnþ1 ¼ M0 − M0 −Mnð Þ ⋅ e−
Δt
T1 ð1Þ
During acquisition, the observed T1 relaxation is altered
in an effective T1* relaxation time by the RF pulses with a
flip angle α and subsequent spoiling, repeated each repeti-
tion time Tr. In Figure 1 T1* relaxation occurs during the
intervals M2-M3, M6–M7, M8–M9, M10–M11 and M12–
M13. The longitudinal magnetization approaches a satu-






¼ 1 − e
−TRT1




Again each magnetization Mn+1 can be calculated from
a previous magnetization Mn with a time interval Δt, but
now according to:




During the T1-sensitizing phase the longitudinal
magnetization Mz is inverted. During the T2-sensitizing
phase the longitudinal magnetization Mz is decreased by
a factor e−
TET2prep
T2 , where TET2prep is the time difference
between the tip-down 90 degree RF pulse in x-direction
and the tip-up 90 degree RF pulse in the –x-direction.
The total acquisition results in 5 measured signals for
each voxel, proportional to the magnetization M2, M6,
M8, M10 and M12 in Figure 1.
The T1 and M0 values are found per voxel by using
equation 1–3 in an iterative method by minimizing the
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Mz and the five signal data points. The T2 relaxation
time is calculated using the extrapolated magnetizations
just prior to the T2-sensitizing phase, M1, and just after
the T2-sensitizing phase, M2, according to:
T2 ¼ − TET2prepln M1=M2ð Þ ð4Þ
Generation of the T1 and T2 maps was implemented
on a standalone version of SyMRI® (SyntheticMR, Sweden)
and required less than 10 seconds on a standard PC.Validation
The MR pulse sequence was implemented on a Philips
Ingenia 3T MR system (Philips Healthcare, Best, the
Netherlands) and was evaluated by phantom studies as









Volunteer 1 Male 25 179 69 68
Volunteer 2 Male 31 193 85 49
Volunteer 3 Male 27 190 100 73
Volunteer 4 Male 48 182 77 50
Volunteer 5 Female 39 178 62 62
Volunteer 6 Male 46 183 85 61
Volunteer 7 Male 33 180 90 54
Volunteer 8 Male 30 188 82 59
Volunteer 9 Male 27 182 74 64
Volunteer 10 Male 29 181 65 86Phantom studies
Test phantoms were manufactured with different con-
centrations of agarose (3-5% agarose in sterile water),
doped with different amounts of gadolinium-Gadovist
([Gd] = 0.02-0.1 mM) each phantom thus representing
specific relaxation times with T1 ~ 200–1800 ms and T2 ~
35–170 ms. Phantoms were randomly distributed in a
plastic container holding water at room temperature. A
physiology simulator for artificial heart triggering was used
and initially set to a heart rate of 60 beats per minute.
A series of 3D-QALAS scans were performed by
intentionally varying some parameters that might affect
the quantification, with the aim to investigate the ro-
bustness of the sequence. The simulated heart rate was
varied from 40–120 bpm, the range previously recom-
mended for cardiac relaxation times mapping [17], and
the flip angle during acquisition, α, was varied from 4 –
8 degrees. Cardiac arrhythmias simulating atrial fibrilla-
tion or variations in the length of the cardiac cycle were
deliberately applied to investigate its effect on the relax-
ation times measurements. Gaussian noise distributions
with three different widths were used to change the
length of the cardiac cycle in order to simulate fibrilla-
tion. Phantom measurements with simulated arrhythmia
were repeated twenty times so that applied noise would
occur randomly over the measurement.
Reference values of T1 were established by using a
standard inversion recovery turbo spin-echo sequence,
with inversion times (TI) varying from 100–5000 ms and
a TR of 10000 ms. Reference values of T2 were established
by using a standard multi echo turbo spin-echo sequence,
with echo times (TE) varying from 10 ms to 200 ms by in-
crements of 10 ms and a TR of 3000 ms.In vivo studies
Ten healthy volunteers with no history of cardiovascular
disease underwent three 3D-QALAS scans, in the same
session, in order to investigate the intra-scan variability
of the method. The left ventricular images were viewed
in short axis orientation. For comparison, three repeated
conventional T1 and T2 measurements were performed
in a mid ventricular 2D short axis slice. For T1 a 3-3-5
MOLLI [12] acquisition was performed and for T2 com-
parison a dual echo GraSE sequence was used, both with
a resolution of 2.0 × 2.0 × 10.0 mm.
Ethics approval was granted and all subjects gave writ-
ten informed consent. Details regarding the subjects are
presented in Table 1.
Mean values and standard deviation of relaxation
times for each individual were calculated from three re-
peated image acquisitions. In each examination, four re-
gions of interests were defined (septal, anterior, lateral
and posterior) in a mid cavity short axis slice. Mean
values and standard deviations of relaxation times were
also calculated for the separate myocardial regions, as an
average of the ten subjects. For analysis of the T1 and
T2 maps a standalone version of SyMRI® (Synthetic MR,
Sweden) was used.
The 3D-QALAS sequence was also validated pre and
post contrast in a 65 year old male with a myocardial in-
farction in the inferolateral region of the left ventricle.




The relation between 3D-QALAS and Inversion Recovery
for T1 respectively Multi Echo for T2 was investigated
using Pearson correlation coefficient. There was a strong
relation between 3D-QALAS and Inversion Recovery
(R = 0.998; N = 10; p<0.01) and between 3D-QALAS and
Multi Echo (R = 0.996; N = 10; p<0.01) for relaxation times
Figure 2 Bland-Altman plot for T1 values at 60 bpm with 3D-QALAS and inversion recovery in phantoms. Thick dashed line represents
overall average difference between measurements (−15.3 ms), thin dashed lines represent 2SD.
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show the distribution of 3D-QALAS and Inversion Recov-
ery respectively Multi Echo in phantoms. Average differ-
ence between the measurements was −15.3 ms for T1 and
3.8 ms for T2. The 2SD range was 60.3 ms for T1 and 7.5
ms for T2.
The relationship between relaxation time measure-
ment with 3D-QALAS and the corresponding reference
values for different heart rates can be seen in Figure 4
for T1 and in Figure 5 for T2. The effect on T1 and T2
measurements when using different radio frequency flip
angles during data acquisition, α, is shown in Figures 6
and 7.
Noise was deliberately applied to the cardiac cycle
length of the phantoms to simulate arrhythmia. The re-
sults of twenty repeated measurements for each noise
level (5% noise, 10% noise and 15% noise) are shown in
Figure 8 for T1 measurements and in Figure 9 for T2
measurements. Mean deviation from a steady cardiacFigure 3 Bland-Altman plot for T2 values at 60 bpm with 3D-QALAS a
average difference between measurements (3.8 ms), thin dashed lines reprcycle length of 60 bpm was at a noise level of 5%: 2.3% for
T1 and −3.32% for T2, at a noise level of 10%: −1.33% for
T1 and −0.04% for T2 and at a noise level of 15%: −22.1%
for T1 and −8.01% for T2.
In vivo study
Left ventricular myocardial relaxation times were suc-
cessfully measured in-vivo using 3D-QALAS, MOLLI,
and the dual echo GraSE sequence in all 10 healthy vol-
unteers. The thirteen short axis slices of the left ven-
tricular myocardium obtained with 3D-QALAS did not
contain any noticeable artifacts or other imperfections,
as demonstrated in Figure 10.
Left ventricular myocardial relaxation times, measured
in-vivo with 3D-QALAS, were compared with their re-
spective reference method and a good agreement was
found, see Table 2. The mean value of T1 in healthy
myocardium by 3D-QALAS was 1083 ± 43 ms (mean ±
SD) and by MOLLI 1089 ± 54 ms. The mean value ofnd multi echo in phantoms. Thick dashed line represents overall
esent 2SD.































Figure 4 Heart rate dependency in T1 measurement with 3D-QALAS. Relationship between longitudinal relaxation time measurements with
3D-QALAS and the corresponding reference values measured with Inversion Recovery for different heart rates (40–120 bpm).
































Figure 5 Heart rate dependency in T2 measurements with 3D-QALAS. Relationship between transverse relaxation time measurements with
3D-QALAS and the corresponding reference values measured with Multi Echo for different heart rates (40–120 bpm).
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Figure 6 Effect on T1 measurement using different radio frequency flip angles, α, during acquisition. Measured longitudinal relaxation
time (T1) with 3D-QALAS for different radio frequency flip angles, α, during data acquisition and corresponding reference values measured with
Inversion Recovery. Radio frequency flip angles are varied from 4 degrees to 8 degrees.
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http://jcmr-online.com/content/16/1/102T2 in healthy myocardium by 3D-QALAS was 50,4 ±
3,6 ms and by Dual Echo 50,3 ± 3,5 ms. Relaxation times
were determined in healthy volunteers and derived from
regions of interest such as the four regions of the short
axis left ventricle that can be seen in Table 2. Values are




























Figure 7 Effect on T2 measurement using different radio frequency fl
(T2) with 3D-QALAS for different radio frequency flip angles, α, during data
Echo. Radio frequency flip angles are varied from 4 degrees to 8 degrees.volunteer. No significant difference in relaxation times
was found between the different myocardial regions.
Bland-Altman plots, Figures 11 and 12, show the dis-
tribution of 3D-QALAS and corresponding reference
methods in ten healthy volunteer. Average difference be-
tween the measurements was −5.8 ms for T1 and 0.1 ms00 150 200
2 (ms)
ip angles, α, during acquisition. Measured transverse relaxation time
acquisition and corresponding reference values measured with Multi





























Figure 8 Effect of deliberately applied arrhythmias on phantom T1 measurements. Gaussian noise distributions with three different widths
(5%, 10% and 15%) were used to change the length of the cardiac cycle, initially 60 beats per minute (bpm), in order to simulate atrial fibrillation.
Deviation in percentage from measurements with 60 bpm and 0% noise can be seen as a function of T1 values measured with 3D-QALAS at a
heart rate of 60 bpm with 0% noise.





























Figure 9 Effect of deliberately applied arrhythmias on phantom T2 measurements. Gaussian noise distributions with three different widths
(5%, 10% and 15%) were used to change the length of the cardiac cycle, initially 60 beats per minute (bpm), in order to simulate atrial fibrillation.
Deviation in percentage from measurements with 60 bpm and 0% noise can be seen as a function of T2 values measured with 3D-QALAS at a
heart rate of 60 bpm with 0% noise.
















Figure 10 3D-QALAS images from a healthy volunteer. The thirteen 3D-QALAS short axis slices T1 maps (left) and T2 maps (right) of the left
ventricular myocardium are shown. Slice 8 is shown on a larger scale. The gray scale indicates 0–2000 ms for T1 and 0–300 ms for T2.
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for T2.
Results of individual myocardial relaxation times for
the ten healthy volunteers investigated with 3D-QALAS
and the corresponding in-vivo reference methods are
shown in Figure 13 for T1 and in Figure 14 for T2. A
two-tailed unpaired Student T-test was used to calculate
whether the differences between population means were
significant. No significant difference in relaxation times
was found between 3D-QALAS and MOLLI (N = 10;
p = 0.65) respectively 3D-QALAS and Dual Echo (N =
10; p = 0.925). Pre and post contrast 3D-QALAS maps
together with a conventional late gadolinium enhance-
ment image from a patient with a myocardial infarction
can be seen in Figure 15.Table 2 Myocardial relaxation times derived from regions of
Cases Region 3D-QALAS T1
T1 (ms)
10 Healthy Septal 1111 ± 46
Anterior 1066 ± 35
Lateral 1072 ± 46
Posterior 1084 ± 32
Averages 1083 ± 43
Mean values and standard deviations of myocardial relaxation times from ten healt
MOLLI and Dual Echo GraSE EPI.Discussion
In order to make myocardial relaxation time mapping
more clinically applicable in a daily routine, improvements
in speed and coverage with maintained accuracy and pre-
cision are desirable. In this work we have developed a fast
and accurate method providing simultaneous acquisition
of T1 maps and T2 maps with coverage of the entire left
ventricular myocardium in a single breath hold.
Relaxation time measurements with 3D-QALAS in
phantoms showed highly accurate results over a large
range of T1 and T2 values, covering both expected con-
trast enhanced and native conditions of myocardial tis-
sue. The method appeared to be robust for changes
in flip angle, heart rate, and arrhythmia during the
measurement.interest in healthy volunteers
MOLLI 3D-QALAS T2 T2-DE
T1 (ms) T2 (ms) T2 (ms)
1096 ± 62 51.1 ± 4.2 51.5 ± 4.4
1071 ± 53 49.3 ± 3.3 49.7 ± 3.0
1088 ± 43 50.2 ± 3.2 50.0 ± 3.3
1103 ± 54 50.9 ± 3.8 50.0 ± 3.0
1089 ± 54 50.4 ± 3.6 50.3 ± 3.5
hy volunteers assessed in four regions within a short axis slice with 3D-QALAS,
Figure 11 Bland-Altman plot for native myocardial T1 values with 3D-QALAS and MOLLI. Each healthy volunteer is represented with one
measurement point. Thick dashed line represents overall average difference between measurements (−5,8 ms), thin dashed lines represent 2SD.
Kvernby et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:102 Page 10 of 14
http://jcmr-online.com/content/16/1/102Performing relaxation time mapping in a whole 3D vol-
ume instead of in a 2D slice is followed by the require-
ment to collect larger quantity of k-space data in one
breath hold. To fulfill this criterion without increasing the
total acquisition time, i.e. the length of the breath hold,
implies that there can only be a limited number of data
points acquired. For the T1 curve only 4 points were mea-
sured, resulting in a dynamic range for 3D-QALAS that
lies at least in the range 200–1800 ms for T1 as shown in
the phantom study. Especially for the low T1 values it was
important to use the simulated magnetization evolution
for the analysis, rather than an exponential fit. In this ana-
lysis a perfect inversion pulse is assumed, which essentially
adds a data point to the measurement: the magnetization
right after the inversion pulse must be equal to minus the
extrapolated magnetization just prior to the inversion
pulse. This assumption makes the analysis more stable
compared to the exponential fit as for example is used in
the MOLLI analysis. Furthermore the 3D-QALAS methodFigure 12 Bland-Altman plot for native myocardial T2 values with 3D
one measurement point. Thick dashed line represents overall average differenneeds an acquisition read out time that is slightly longer, <
230 ms, together with a larger slice thickness, 12 mm,
than existing 2D relaxation time mapping methods
[12,13,18] to be able to sample the larger quantity of data
required to cover the whole 3D volume and to maintain
good in-plane spatial resolution with a high image quality.
The dynamic range of T1 in 3D-QALAS can also be re-
lated to that of saturation recovery and inversion recovery
based T1-mapped methods. In 3D-QALAS the magneti-
zation just prior to the inversion pulse is not fully relaxed
since it is placed at only one cardiac cycle after the T2
preparation pulse. The magnetization is therefore more
likely to be in the interval 0.5 – 1.0 times the unsaturated
magnetization and hence in the interval −0.5 - −1.0 after
the inversion. This places the dynamic range of T1 of 3D-
QALAS somewhere between saturation recovery and in-
version recovery based T1-mapping methods.
The results also showed that the T2 measurements of
3D-QALAS were valid in the range of at least 35 – 170-QALAS and Dual Echo. Each healthy volunteer is represented with
ce between measurements (0,1 ms), thin dashed lines represent 2SD.
Figure 13 Individual myocardial T1 values from 3D-QALAS and MOLLI. Values are derived from four regions of interests (septal,anterior,lateral
and posterior) in a mid-cavity short axis slice from three repeated measurements and are displayed as mean values representing each measurement.
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mated by setting requirements on the signal intensity of
the exponential decay curve during the T2 sensitizing
phase. The upper limit of T2 can be defined by requiring
that the signal intensity should at least have decreased to
90% at the end of the measurement (corresponding to
e−
TE
T2 ¼ 0:9). The lower limit of T2 can be defined by re-
quiring that the signal intensity should at most have de-
creased to 10% (corresponding to e−TET2 ¼ 0:1) at the end
of the measurement, such that the signal does notFigure 14 Individual myocardial T2 values from 3D-QALAS and Two-P
(septal, anterior, lateral and posterior) in a mid-cavity short axis slice from thre
each measurement.disappear in the noise level. Using these requirements,
in combination with the chosen TE = 50 ms, the ex-
pected dynamic range of T2 values in our experiment
becomes [22–475] ms, which is larger than the evaluated
range.
The gradient echo sequence used for quantification
could either be low flip-angle spoiled gradient echo, as
suggested for 3D-QALAS, or high flip-angle balanced
SSFP, as common in the MOLLI approach. As off-
resonance effects may be challenging in 3D applicationoint Multi Echo (ME). Values are derived from four regions of interests



























Figure 15 Native and post contrast images from a 65 years old male with a lateral myocardial infarction. Pre and post contrast 3D-QALAS
maps together with a conventional late gadolinium enhancement image illustrates the area of infarction.
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QALAS. The penalty of using spoiled gradient echo is the
intrinsically lower signal strength compared to bSSFP.
The penalty in SNR by choosing a low flip-angle spoiled
gradient echo should however be weighted against the
benefits of using a true 3D acquisition, including a full
coverage of the heart, and less tissue moving in and out of
the excited volume.
Quantification methods can be sensitive to inhomo-
geneity in the radio frequency field strength (B1), which
would affect the actual local flip angle. This makes the
flip angle dependency of quantification techniques rele-
vant. The results shows that the 3D-QALAS sequence
was insensitive to RF flip angles changes in the range of
4° - 8°, which can be interpreted as the relaxation time
calculation is relatively insensitive to changes in the B1
field.
Heart rate dependency has proven to be a challenge
for myocardial T1 mapping methods, especially at longlongitudinal relaxation times [19]. We did not see such
dependence within the tested range of heart rate with
the method proposed in this work, either for T1 mea-
surements or for T2 measurements, as can be seen in
Figures 4 and 5. This may be a result of the use of a
simulation of the full magnetization evolution during the
acquisition, which included saturation effects due to
long T1 relaxation times in comparison to one heartbeat.
This seems to be a more robust approach than using the
assumption that the magnetization has returned to M0
after a certain delay time. In theory, the dynamic range
might be affected by heart hate. The dynamic range be-
comes eventually slightly lower at higher heart rates
than for lower heart rates since the recovery of the
magnetization vector is less when the total acquisition
time is shorter. This assumed loss of dynamic range
was not evident in the volunteer with the highest heart
rate, 86 beats/min. The proposed method is robust to
small random changes in cardiac cycle lengths, as was
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noise distributions applied to the length of the cardiac
cycle of 5% and 10% has a minor effect on the quantifi-
cation of relaxation times. The error seen at an applied
noise level of 15% deviation from a steady cardiac cycle
length is most probably related to the exclusion of ex-
tremely short cardiac cycles. Cardiac cycles longer than
the set value on the scanner usually pose no problem
for the data acquisition to be completed within the ex-
pected cardiac cycle length, other than motion artifacts
if the data acquisition does not occur at the right moment
in the cardiac cycle. However, cardiac cycles much shorter
than the set value will result in incomplete data and the
need to complete the acquisition in the next cardiac cycle.
This will thus introduce a fault in the calculation of relax-
ation times. To overcome this problem, a higher heart rate
than the actual mean heart rate can be set on the scanner.
Left ventricular myocardial relaxation times with 3D-
QALAS were compared with a 3-3-5 MOLLI for T1
measurement, a dual echo GraSE sequence for T2 meas-
urement and consistent results were found between 3D-
QALAS and the corresponding reference method. In-vivo
relaxation time measurements with 3D-QALAS were in
accordance with previously published results for both T1
and T2 [13,20]. Reference values for healthy myocardial
tissue seem to differ between manufacturers and between
different quantification methods. According to a recently
published study [21], several T1-mapping methods suffer
from poor absolute accuracy and reference values from
different relaxation time mapping methods might thus be
difficult to compare with each other. Native T1 values at
3T from inversion recovery based T1 mapping methods
have shown a spread from < 900 ms to > 1300 ms in
healthy volunteers [22,23].
We have evaluated the accuracy and intra-scan variabil-
ity of 3D-QALAS using phantom studies and in-vivo stud-
ies on healthy volunteers. The results are promising, but
further evaluation post-contrast and in cardiac disease is
necessary before assessment of extracellular volume or
application of the method in larger clinical studies. One
patient with myocardial infarction is however included
in the study to demonstrate the method at short T1,
post-contrast.
The presented original version of 3D-QALAS provides
13 slices of the left ventricular volume within a breath
hold of 15 heartbeats. The sequence can be modified to
a shortened version, in which k-space is covered in two
segments instead of three segments as in the original
version. We have successfully tested a version covering
eight slices within a breath hold of 10 heartbeats, still
giving the same resolution as the original version but
thus with less ventricular coverage. This modified ver-
sion enables use of this method in patients having diffi-
culty holding their breath and gives the possibility offull coverage of left ventricular volume in two breath
holds.
3D-QALAS enables relaxation time mapping of both T1
and T2 in a 3D volume in a single breath hold. Moreover,
the T1 and T2 maps are inherently co-registered, avoiding
post-processing registration errors. It is reasonable to be-
lieve that quantitative information from both these param-
eters facilitates better differentiation between myocardium
affected by e.g. edema, fibrosis, storage diseases and nor-
mal myocardium.
Conclusions
The 3D-QALAS principle has demonstrated good accur-
acy and intra-scan-variability both in-vitro and in-vivo. It
allows a rapid acquisition and provides quantitative infor-
mation of both T1 and T2 relaxation times in the same
scan with full coverage of the left ventricle, enabling the
method to be clinically applicable to a broader spectrum
of cardiac disorders.
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